ENTITY
TYK Medicines

TYK Medicines (2410 HK)

47
Analysis
Health Care • China
TYK Medicines is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of small molecule pharmaceutical products. The company's pipeline includes drug candidates for treating various cancers, such as breast cancer, prostate cancer, and solid tumors. TYK Medicines was founded in 2017 and is headquartered in Huzhou, China.
more
bullish•TYK Medicines
•08 Aug 2026 20:11

Primer: TYK Medicines (2410 HK) - Aug 2026

TYK Medicines is a clinical-stage biopharmaceutical company with a pipeline of over ten small molecule drug candidates focused on oncology,...

Logo
111 Views
Share
x